PECAM1 and acute respiratory distress syndrome: Hence, targeting CD31 could not only specifically carry drugs to lung tissues but also block the interaction between endothelial cells and neutrophils, eventually preventing neutrophil migration and infiltration to alleviate ALI/ARDS.